Education
About Us
Working with TipRanks
Follow Us
Philogen SpA (DE:78Q)
STUTTGART:78Q
L19tnf, L19tnf And Tmz, L19tnf And Ccnu, L19tnf Monotherapy, L19tnf And Tmz In Recurrent Astrocytoma, L19tnf And Ccnu In Recurrent Astrocytoma, L19tnf Monothery In Recurrent Oligodendroglioma
Glioma
Phase II
Not Yet Recruiting
A Study to Evaluate the Safety and Efficacy of L19TNF With Alkylating Chemotherapy for Patients With Recurrent IDH-mutant Astrocytoma or Oligodendroglioma
Jul 30, 2025
―
[68Ga]Ga-Oncoacp3
Prostate Cancer, Prostate Cancer Metastatic Disease, Psa Level Greater Than 0.2
Phase I
Recruiting
A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoACP3 in Patients With Prostate Cancer
Feb 17, 2025
―
[68Ga]Ga-Oncocaix
Clear Cell Renal Cell Carcinoma (Ccrcc)
Phase I
Recruiting
A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoCAIX in Patients With CAIX-positive Cancer
Feb 17, 2025
―
L19il2, [177Lu]Lu-Oncofap-23
Fap
Phase I
Not Yet Recruiting
A Study to Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23 Alone or in Combination With L19-IL2 as a Treatment of Metastatic FAP-positive Solid Tumors
Oct 10, 2024
―
Lomustine, L19tnf
Glioblastoma
Phase II
Recruiting
A Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence
Mar 04, 2024
―
L19tnf, L19il2/L19tnf, L19il2, Keytruda®
Melanoma Stage Iii, Melanoma Stage Iv
Phase II
Recruiting
Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients
Jan 26, 2024
―
[68Ga]Ga-Oncofap Administration
Colorectal Cancer, Breast Cancer, Oesophageal Cancer, Pancreas Adenocarcinoma
Phase I
Completed
A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors
Dec 15, 2022
―
F8il10
Rheumatoid Arthritis
Phase I
Not Yet Recruiting
Safety and Preliminary Signs of Efficacy of F8IL10 for Intra-articular Treatment
Nov 03, 2022
―
F16il2, Nivolumab, Fixed Dose
Non-Small Cell Lung Cancer (Nsclc)
Phase I/II
Unknown
F16IL2 in Combination With Nivolumab in Patients With Non-small Cell Lung Cancer
Jun 23, 2022
―
L19il2/L19tnf
Merkel Cell Carcinoma, Bcc - Basal Cell Carcinoma, Scc - Squamous Cell Carcinoma, Keratoacanthoma Of Skin, Malignant Adnexal Tumors Of The Skin (Mats), Tumors From Cutaneous T-Cell Lymphoma (Ctcl), Kaposi Sarcoma
Phase II
Recruiting
L19IL2/L19TNF in Skin Cancer Patients
Apr 07, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Philogen SpA (78Q) have in its pipeline
78Q is currently developing the following drugs: L19tnf, L19tnf And Tmz, L19tnf And Ccnu, L19tnf Monotherapy, L19tnf And Tmz In Recurrent Astrocytoma, L19tnf And Ccnu In Recurrent Astrocytoma, L19tnf Monothery In Recurrent Oligodendroglioma, [68Ga]Ga-Oncoacp3, [68Ga]Ga-Oncocaix. These drug candidates are in various stages of clinical development as the company works toward FDA approval.